Pleiotropic Effects of PI-3' Kinase/Akt Signaling in Human Hepatoma Cell Proliferation and Drug-Induced Apoptosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pleiotropic Effects of PI-3' Kinase/Akt Signaling in Human Hepatoma Cell Proliferation and Drug-Induced Apoptosis

Published:2006-12-01 Issue:1 Volume:1090 Page:1-17
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:Annals of the New York Academy of Sciences

Author:

ALEXIA C.,BRAS M.,FALLOT G.,VADROT N.,DANIEL F.,LASFER M.,TAMOUZA H.,GROYER A.

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1196/annals.1378.001/fullpdf

Reference60 articles.

1. Viral pathogenesis of hepatocellular carcinoma in the United States,

2. Pathogenesis of Hepatocellular Carcinoma

3. Therapy of Unresectable Hepatocellular Carcinoma

4. Hepatocyte death in hepatocarcinogenesis

5. Liver Regeneration

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CHMP4C promotes the progression and cisplatin resistance of non-small cell lung cancer via the PI3K/AKT signaling pathway;2023-08-22

2. Lactate-related metabolic reprogramming and immune regulation in colorectal cancer;Frontiers in Endocrinology;2023-01-26

3. Insulin-like Growth Factor I Receptor: A Novel Target for Hepatocellular Carcinoma Gene Therapy;Mini-Reviews in Medicinal Chemistry;2019-01-29

4. Metformin Counteracts HCC Progression and Metastasis Enhancing KLF6/p21 Expression and Downregulating the IGF Axis;International Journal of Endocrinology;2019-01-10

5. (–)-Epigallocatechin-3-gallate Down-regulates Doxorubicin-induced Overexpression of P-glycoprotein Τhrough the Coordinate Inhibition of PI3K/Akt and MEK/ERK Signaling Pathways;Anticancer Research;2017-10-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3